Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
INmune Bio Inc. - Common stock
(NQ:
INMB
)
1.395
+0.015 (+1.09%)
Streaming Delayed Price
Updated: 2:59 PM EDT, Apr 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about INmune Bio Inc. - Common stock
< Previous
1
2
3
4
5
Next >
INMB Stock Rises Pre-Market – What Did The FDA Say About Its Alzheimer’s Trial?
↗
February 12, 2026
Via
Stocktwits
INMUNE BIO INC (NASDAQ:INMB) Reports Narrower-Than-Expected Q3 2025 Loss
↗
October 30, 2025
INmune Bio (INMB) reported a narrower-than-expected Q3 2025 loss, sparking a positive after-hours market reaction for the clinical-stage biotech firm.
Via
Chartmill
Earnings Scheduled For October 30, 2025
↗
October 30, 2025
Via
Benzinga
INmune Bio (INMB) Q2 Loss Widens 110%
↗
August 07, 2025
Via
The Motley Fool
Topics
Intellectual Property
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
August 07, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
What's going on in today's pre-market session
↗
August 04, 2025
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 04, 2025
Via
Benzinga
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
↗
July 28, 2025
Via
Benzinga
INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge?
↗
July 28, 2025
Following the announcement of TNF inhibitor, INmune Bio Inc. stock surged by 24.72% in after-hours trading on Friday.
Via
Benzinga
'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday
↗
July 04, 2025
Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.
Via
Benzinga
Which stocks have an unusual volume on Thursday?
↗
July 03, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via
Chartmill
This Textron Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
↗
July 01, 2025
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
↗
June 30, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Crude Oil Moves Lower; Joby Aviation Shares Surge
↗
June 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 30, 2025
Via
Benzinga
Which stocks are moving on Monday?
↗
June 30, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Alzheimer's Setback Hits INmune Bio Stock, But FDA Hopes Remain
↗
June 30, 2025
INmune Bio's Alzheimer's drug XPro showed targeted benefits in patients with brain inflammation, but misses the main trial endpoint.
Via
Benzinga
Dow Gains Over 100 Points; Chicago PMI Weakens In June
↗
June 30, 2025
Via
Benzinga
Topics
Stocks
Gapping stocks in Monday's session
↗
June 30, 2025
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial
↗
June 30, 2025
The primary endpoint of the study was not met in the intent-to-treat population, the company said.
Via
Stocktwits
Get insights into the top gainers and losers of Monday's pre-market session.
↗
June 30, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 30, 2025
Via
Benzinga
Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket
↗
June 30, 2025
Via
Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
June 27, 2025
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Via
Chartmill
INmune Bio Stock Soars Friday On Alzheimer's Treatment Hopes
↗
June 27, 2025
INmune Bio stock rose sharply on high volume ahead of topline Phase 2 trial data for XPro in early Alzheimer's, expected on June 30.
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
June 27, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
June 27, 2025
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
June 27, 2025
Via
Benzinga
INmune Bio Skyrockets After-Hours On Alzheimer’s Trial Buzz; Retail Bulls Bet Big Before Data Reveal Next Week
↗
June 27, 2025
INmune is also developing XPro for treatment-resistant depression and exploring other immune-driven conditions like cancer and rare skin disorders.
Via
Stocktwits
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
